Individuals Stopping Weight-Loss Medications Regain Pounds Four Times Faster Compared to People Using Diet and Exercise
New research reveals that people who come off popular GLP-1 drugs like Wegovy and Mounjaro tend to recover reduced body mass much more quickly than those who stop conventional lifestyle plans.
Published data in a leading medical journal points out that while obese people frequently drop a large proportion of their body weight while using the jabs, the mass comes back at an average rate of nearly a kilo each month upon discontinuation.
"Users purchasing these drugs should be informed of the danger of fast rebound weight gain when the therapy ends," stated researcher Dr. Susan Jebb.
Such speed of regain suggests a return to original mass in about 18 months.
Analyzing Treatments
The analysis, which examined dozens of studies involving over 9,000 of participants, compared the effects of GLP-1 agonists with conventional dieting.
The team note that people who shed pounds through dieting typically experience a more gradual creep back—around 100 grams monthly—once they finish.
The Reason for the Quick Regain
Experts propose the way of the injections accounts for the accelerated regain.
GLP-1 drugs copy a body's own chemical called glucagon-like peptide-1, which helps regulate appetite.
"Long-term administration of GLP-1 concentrations several times higher than normal may cause the body to produce less of its endogenous GLP-1, and may also lessen sensitivity to its effects," said Dr. Adam Collins, a nutrition expert.
"Discontinuation of this medication leads to appetite is no longer kept in check, making binge eating far more likely."
A Chronic Condition?
Health authorities advise the injections for individuals with weight-linked medical conditions, alongside recommended diet and exercise modifications.
A number of clinicians say that, given the significant potential of weight regain, the treatment might need to be life-long.
This perspective is reinforced by drug manufacturers, who note that the results "emphasize the long-term nature of excess weight," akin to managing conditions like diabetes.
Patient Testimonies
Individuals who have discontinued the jabs report a intense return of cravings.
"It felt as if a switch flipping and I was suddenly extremely hungry," described an individual.
This challenge is exacerbated if individuals have not developed lasting lifestyle or habit changes during therapy.
Widespread Use
Recent estimates suggest that a significant number of adults in the UK have tried these injections in the last 12 months, with interest continuing to grow.
- Use is higher among females than men.
- The 40s and 50s demographic shows the greatest level of interest.
- A large proportion obtain the medications through private healthcare rather than the NHS.
In conclusion, clinicians caution that while these medications are effective tools for weight loss, they are not a permanent cure and long-term success hinges on integrated lifestyle management.
